Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Apr 28, 2020

SELL
$16.25 - $35.28 $4,062 - $8,820
-250 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$14.17 - $20.3 $3,542 - $5,075
250 New
250 $7,000

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $386M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Capital Wealth Alliance, LLC Portfolio

Follow Capital Wealth Alliance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Wealth Alliance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Wealth Alliance, LLC with notifications on news.